Alkem Laboratories Limited (NSE:ALKEM)
5,642.00
+40.00 (0.71%)
Jul 24, 2026, 3:30 PM IST
Alkem Laboratories Stock Forecast
Stock Price Forecast
According to 20 analysts polled by S&P Global, Alkem Laboratories stock has a consensus rating of "Buy" and an average price target of ₹5,965. The average 1-year stock price forecast is 5.72% higher than the current stock price, while the lowest is ₹4,200 (-25.56%) and the highest is ₹6,890 (+22.12%).
Price Target: ₹5,965 (+5.72%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 29, 2026.
Analyst Ratings
The average analyst rating for Alkem Laboratories stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 6 | 6 | 7 |
| Buy | 6 | 6 | 6 | 6 | 6 | 5 |
| Hold | 6 | 7 | 7 | 4 | 4 | 4 |
| Sell | 2 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 3 | 3 | 3 | 4 | 4 | 4 |
| Total | 21 | 21 | 21 | 20 | 20 | 20 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Maintains ₹5,900 | Hold | Maintains | ₹5,900 | +4.57% | May 29, 2026 |
| Jefferies | Jefferies | Buy Maintains ₹6,500 | Buy | Maintains | ₹6,500 | +15.21% | May 29, 2026 |
| ICICI Securities | ICICI Securities | Buy Maintains ₹6,500 → ₹6,850 | Buy | Maintains | ₹6,500 → ₹6,850 | +21.41% | May 28, 2026 |
Financial Forecast
Revenue This Year
165.37B
from 147.12B
Increased by 12.40%
Revenue Next Year
182.17B
from 165.37B
Increased by 10.16%
EPS This Year
196.74
from 204.53
Decreased by -3.81%
EPS Next Year
226.20
from 196.74
Increased by 14.98%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.